ArticleInternational urology and nephrology2026
Integrated single-cell and bulk transcriptomic analysis identifies epithelial cell-related biomarkers and immune subtypes in focal segmental glomerulosclerosis.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFocal segmental glomerulosclerosis (FSGS) is a major cause of nephrotic syndrome and chronic kidney disease, characterized by podocyte injury and glomerular scarring. Its heterogeneity complicates early diagnosis and treatment.
methodsWe integrated bulk and single-cell RNA-seq datasets (GSE200818, GSE200828, and GSE176465) to investigate epithelial cell-related molecular alterations in FSGS. Differentially expressed genes (DEGs) were identified and analyzed for functional enrichment. Machine learning algorithms (random forest and support vector machine) were applied to construct a diagnostic gene signature. Immune cell infiltration was assessed using ssGSEA, and molecular subtypes were defined via consensus clustering. Independent datasets (GSE133288 and GSE108109) were used for validation.
resultsA total of 133 epithelial cell-associated DEGs were identified. Enrichment analysis indicated transcriptional regulation and viral infection pathways. Three diagnostic genes-B4GALT5, CSRNP1, and CYP3A5-were selected and shown to have excellent diagnostic accuracy (AUC > 0.97) in both discovery and validation cohorts, including podocyte-enriched samples. Immune profiling revealed increased infiltration of activated CD8⁺ T cells, NK cells, and dendritic cells in FSGS, with B4GALT5 positively correlated with multiple immune subsets. Consensus clustering stratified patients into two molecular subtypes with distinct immune features.
conclusionsThis integrative analysis identifies epithelial cell-related biomarkers and immune-associated subtypes in FSGS, providing promising tools for diagnosis and patient stratification. While robust across multiple datasets, further experimental validation is needed to confirm mechanistic relevance.
Indexed as
Identifiers
41872652What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.